Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast® range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.
"This agreement with Horus Pharma demonstrates Paragon's commitment to partnering with companies that are dedicated to elevating eye care in the U.S.," Patrick Witham, president and CEO of Paragon BioTeck, says. "It is also an example of Paragon's ongoing commitment to further develop and foster an unparalleled network of collaborative partners."
Martine Claret, president of Horus Pharma, is also excited about the partnership.
"Our partnership with Paragon is a significant milestone in our company's global commercialization efforts," she says. "Ilast® is an important advancement in eye care because it is the only preservative, fragrance and alcohol-free line of ocular hygiene and lid care products available in the U.S."
Study reveals the role of eye movements in Parkinson's disease